Navigation Links
Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
Date:10/3/2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... WALTHAM, Mass., Dec. 14 Lionbridge ... it has signed a new, three-year master ... company with products and services that serve ... agreement Lionbridge will become the sole provider ... which includes regulatory, marketing, training, human resources, ...
(Date:12/14/2009)... - Results From a Survey Conducted by UCB Assessing ... Countries , , - A third of ... impacts their enjoyment of the festive season, ... shopping for gifts, preparing holiday ... difficult to do, - Nearly ...
(Date:12/11/2009)... 10 December 2009 -- Researchers have discovered a new explanation ... The more excess copies of a certain gene, the more ... X-chromosome; and it is suspected that it is the amount ... results are being published in the American Journal of ... the group of Guy Froyen connected to VIB, a life ...
(Date:12/11/2009)... Calif., Dec. 11 Marrone Bio Innovations ... executive management team. Mr. Chris Hildreth joined MBI ... is responsible for expanding all commercial aspects of ... functions. Dr. Kin Sing (Ray) Lam joined MBI ... the company,s development efforts in scaling its broad ...
Breaking Biology Technology:Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 2Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 3Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 2Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 3Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 4Amount of gene surplus determines severity of mental retardation in males 2Marrone Bio Innovations Announces Two New Executive Appointments 2Marrone Bio Innovations Announces Two New Executive Appointments 3
... March 5 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ... results for the fourth quarter and year ended December ... results in our Medical Products Business and were able ... initiatives despite a challenging year for TAXUS," said Dr. ...
... appealed, delisting scheduled for March 12, 2009 NEW YORK, ... KERX ) today announced that it received a letter ... that the Company had failed to regain compliance with ... have a minimum of $2,500,000 in stockholders, equity, or ...
... Inc., announced today that it has successfully completed a ... Capital on behalf of the MPM Bio IV NVS ... of a Phase 1/2 human clinical study of its ... disease undergoing surgery for arteriovenous fistula (AVF) creation. Additionally, ...
Other Biology Technology:Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 2Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 3Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 4Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 5Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 6Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 7Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 8Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 9Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 10Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 11Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 12Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 13Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 14Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 15Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 16Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 17Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 18Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 19Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 20Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 21Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 22Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 23Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 24Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 25Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 26Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 27Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 28Keryx Biopharmaceuticals Inc. Announces Receipt of Nasdaq Delisting Notification 2Keryx Biopharmaceuticals Inc. Announces Receipt of Nasdaq Delisting Notification 3Keryx Biopharmaceuticals Inc. Announces Receipt of Nasdaq Delisting Notification 4Proteon Therapeutics Completes $38M Equity Financing; Initiates Phase 1/2 Clinical Study of PRT-201 in Hemodialysis Patients and Signs Option Agreement With Major Pharmaceutical Company 2
(Date:12/11/2009)... , Montreal, December 11, 2009 Canadian ... cancer. In the December 11 edition of the prestigious ... de Montral and the Universit de Sherbrooke explain how ... activity of cytokines, hormones that are culprits in cancer-prone ... people exposed to asbestos. , "Excessive cytokine activity ...
(Date:12/11/2009)... CORVALIS, ORFruit growers, profits have traditionally been ... climates where growing seasons can be short. ... developed varieties are being introduced that offer ... the offseasonresulting in economic bonuses for both ... new varieties of blackberry called "primocane-fruiting", which ...
(Date:12/11/2009)... roe of hake, lumpsucker and salmon is the best dietary ... by researchers at the University of Almera (UAL). The scientists ... found all of these contained high levels of these fatty ... now there had been no precise understanding of the nutritional ... of researchers from the UAL has now shown that this ...
Breaking Biology News(10 mins):Scientists identify natural anti-cancer defenses 2New management methods extend blackberry season 2Roe of marine animals is best natural source of omega-3 2DaVita com Provides Easy Recipes to Plan Your Fathers Day Dinner 49539 1DaVita com Provides Easy Recipes to Plan Your Fathers Day Dinner 49539 2DaVita com Provides Easy Recipes to Plan Your Fathers Day Dinner 49539 3Last Day of Special Olympics Minnesotas 2009 Summer Games 49537 1Last Day of Special Olympics Minnesotas 2009 Summer Games 49537 2Last Day of Special Olympics Minnesotas 2009 Summer Games 49537 3RSA Designated as the Leader in One Time Password Market by Frost 26 Sullivan 8936 1RSA Designated as the Leader in One Time Password Market by Frost 26 Sullivan 8936 2RSA Designated as the Leader in One Time Password Market by Frost 26 Sullivan 8936 3RSA Designated as the Leader in One Time Password Market by Frost 26 Sullivan 8936 4
... reduce age-related macular degeneration ,(AMD) which is the major cause ... the third cause of global blindness, according to,a study published ... , There are two types of AMD, wet and dry. ... loss. A team of researchers across seven European,countries and co-ordinated ...
... in the western U.S., the New Zealand mud snail currently ... into rivers and tributaries, according to a Penn State team ... but are not good fish food replacements for the native ... the shell," says Edward P. Levri, associate professor of biology ...
... Arctic Ocean warms this century, shellfish, snails and other ... of the northern Atlantic that was interrupted by cooling ... of geology at the University of California, Davis, and ... Climate models predict a nearly ice-free Arctic Ocean by ...
Other Biology News:Eat oily fish at least once a week to protect your eyesight in old age 2Tiny invasive snail impacts Great Lakes, alters ecology 2Tiny invasive snail impacts Great Lakes, alters ecology 3Pacific shellfish ready to invade Atlantic 2
... the industry standard microarray image analysis software ... and analysis tools, visualizations, automation capabilities, performance ... included with every GenePix scanner, and it ... and all types of arrays. A wide ...
... For applications not requiring confocal, the BD ... to the Pathway 435. And, the Pathway ... later applications require it. ... elect to use the laser autofocus, camera ...
... pump, available in a single and twin head, ... design. With the most compact, lightweight package in ... in portable air and gas applications., Available ... T2-01TH). , Delivers 1.5 and 2.0 liters per ...
... Kit containing Vaginal Keratinocyte Progenitors, Rabbit, ... 20% FBS and 10% DMSO at passage ... of optimized medium.This cell culture is supplied ... to provide an additional 6 months of ...
Biology Products: